Managing Lipolytic Complications: Prevention, Recognition, and Treatment
Injectable lipolytics — deoxycholic acid (DCA) and phosphatidylcholine/DCA combinations — are among the most technically demanding of all aesthetic injectables to administer safely. The reason is straightforward: DCA is cytolytic by design. It destroys cells. In the correct tissue plane, targeting subcutaneous adipocytes, this is precisely the therapeutic mechanism. In the wrong plane, at the wrong depth, or with incorrect product placement, it destroys non-target cells — dermis, muscle, nerve — with consequences that range from prolonged discomfort to visible, permanent injury.
Lipolytic Body Contouring: Off-Label Applications for Aesthetic Practitioners
The submental zone is the best-evidenced and most widely discussed lipolytic application — but it is far from the only one. In international aesthetic practice, particularly in the Korean market where lipolytic treatments have been administered at high volume for over two decades, injectable lipolytics are used routinely across multiple body zones to address localised fat deposits that patients find resistant to diet and exercise and that significantly affect their confidence and comfort.
Lipolytic Injectables: The Complete Practitioner's Guide
Injectable lipolytics — agents that chemically destroy subcutaneous fat cells — represent one of the most technically specific and outcome-dependent treatments in non-surgical aesthetic medicine. When patient selection is correct, the treatment zone is appropriate, the product and protocol are sound, and the patient's expectations are accurately set, injectable lipolytics produce permanent, visible, and highly valued results. When any of these elements is wrong, the risk of adverse outcomes — prolonged swelling, irregular contour, nerve injury — increases substantially.
